Related Experiment Video
Updated: Aug 26, 2025

Author Spotlight: Mitochondrial Remodeling in Skeletal Muscle
Published on: December 1, 2023
Functional remodelling of perinuclear mitochondria alters nucleoplasmic Ca2+ signalling in heart failure
Julia Voglhuber1,2, Michael Holzer2,3, Snježana Radulović4
1Department of Cardiology, Medical University of Graz, Graz, Austria.
Abstract:
Mitochondrial dysfunction in cardiomyocytes is a hallmark of heart failure development. Although initial studies recognized the importance of different mitochondrial subpopulations, there is a striking lack of direct comparison of intrafibrillar (IF) versus perinuclear (PN) mitochondria during the development of HF. Here, we use multiple approaches to examine the morphology and functional properties of IF versus PN mitochondria in pressure overload-induced cardiac remodelling in mice, and in non-failing and failing human cardiomyocytes. We demonstrate that PN mitochondria from failing cardiomyocytes are more susceptible to depolarization of mitochondrial membrane potential, reactive oxygen species generation and impairment in Ca2+ uptake compared with IF mitochondria at baseline and under physiological stress protocol. We also demonstrate, for the first time to our knowledge, that under normal conditions PN mitochondrial Ca2+ uptake shapes nucleoplasmic Ca2+ transients (CaTs) and limits nucleoplasmic Ca2+ loading. The loss of PN mitochondrial Ca2+ buffering capacity translates into increased nucleoplasmic CaTs and may explain disproportionate rise in nucleoplasmic [Ca2+] in failing cardiomyocytes at increased stimulation frequencies. Therefore, a previously unidentified benefit of restoring the mitochondrial Ca2+ uptake may be normalization of nuclear Ca2+ signalling and alleviation of altered excitation-transcription, which could be an important therapeutic approach to prevent adverse cardiac remodelling. This article is part of the theme issue 'The cardiomyocyte: new revelations on the interplay between architecture and function in growth, health, and disease'.
Insights
Perinuclear (PN) mitochondria in failing heart cells are more vulnerable to dysfunction than intrafibrillar (IF) mitochondria. Restoring PN mitochondrial calcium uptake may normalize nuclear calcium signaling and prevent heart failure progression.
Area of Science:
- Cardiology
- Mitochondrial Biology
- Cellular Physiology
Background:
- Mitochondrial dysfunction is central to heart failure.
- Distinct mitochondrial subpopulations (intrafibrillar and perinuclear) exist, but their roles in heart failure are not well-compared.
Purpose of the Study:
- To compare the functional properties of intrafibrillar (IF) versus perinuclear (PN) mitochondria during heart failure development.
- To investigate the role of PN mitochondria in regulating nuclear calcium signaling.
Main Methods:
- Studied mitochondrial morphology and function in mouse models of pressure overload-induced cardiac remodeling.
- Examined cardiomyocytes from non-failing and failing human hearts.
- Utilized multiple biochemical and imaging approaches to assess mitochondrial membrane potential, reactive oxygen species generation, and calcium uptake.
Main Results:
- PN mitochondria in failing cardiomyocytes exhibit greater susceptibility to depolarization, increased reactive oxygen species production, and impaired calcium uptake compared to IF mitochondria.
- PN mitochondrial calcium uptake normally shapes nucleoplasmic calcium transients and limits nuclear calcium loading.
- Loss of PN mitochondrial calcium buffering capacity in heart failure leads to elevated nucleoplasmic calcium transients.
Conclusions:
- PN mitochondria are more vulnerable to dysfunction in heart failure than IF mitochondria.
- Impaired PN mitochondrial calcium buffering contributes to altered nuclear calcium signaling in failing cardiomyocytes.
- Restoring PN mitochondrial calcium uptake presents a potential therapeutic strategy to normalize nuclear calcium signaling and prevent adverse cardiac remodeling.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure I: Introduction

